Following a Colorado Springs court case where the desire of an Alcor member to be cryopreserved was upheld, the local paper ran this story on Alcor: Cryonics lab Alcor, holder of Springs woman’s remains, takes low-key approach Update: Link now goes to the Wayback Machine.
“Some banking on cryonically freezing after death.”
“With medical advances, many put faith in freezing.”
“A science without a deadline.” Update: Link now goes to the Wayback Machine.
Alcor has implemented a new whole-body cryopreservation procedure which uses a new cryoprotectant solution, M22, licensed from 21st Century Medicine. The new cryoprotectant is perfused throughout the entire body using the same procedures required for glycerol cryoprotection; but while it cryoprotects the torso, arms, and legs, we are confident that it is also vitrifying the […]
In the previous Alcor News we reported that Alcor has acquired the prototype of an Intermediate Temperature Storage (ITS) device developed by Brian Wowk of 21st Century Medicine. (For an explanation of why ITS is desirable, please check the explanatory section in Alcor News #13 dated July 1st, 2003.) Our new lab assistant, Todd Huffman, […]
Maintaining patients at an intermediate temperature means keeping them warmer than liquid nitrogen, but cold enough to inhibit biological decay. For years we have wanted to provide this option. On June 14th, we came much closer to our goal. Why Intermediate Temperature Storage is Necessary If cryoprotective perfusion is performed successfully with a high terminal […]